Found vs Embody: Biology-First Care vs Low-Cost GLP-1 Plans
Found vs Embody answers a common choice: a personalized, biology-first weight loss program that accepts most insurance versus a lean, low-cost GLP-1 telehealth option with fast delivery. Early verdict: choose Found if you want a medically supervised, biology-based plan that can work with insurance; choose Embody if you prioritize the lowest cash price for compounded semaglutide and fast shipping.
Start Found — see plans starting as low as $39
How Found and Embody differ at a glance
Both platforms provide telehealth-prescribed GLP-1 options, but they take different approaches. Found emphasizes personalized programs built around metabolic biology and accepts insurance for many patients. Embody emphasizes low, flat cash pricing for compounded GLP-1s, fast free shipping, and no insurance requirement.
Distinctive differences to weigh
1. Care model and personalization
Found: Offers a personalized medically supervised weight loss program that starts with a medical evaluation to tailor treatment to hormones, blood sugar regulation, sleep, and behavior. The provider describes a holistic whole-body approach rather than prescribing a single medication protocol for all patients.
Embody: Focuses on a prescription-forward, no-frills model. It provides clinician review and telemed visits for compounded semaglutide and tirzepatide but emphasizes straightforward medication delivery without integrated coaching or advanced monitoring features.
2. Pricing structure and insurance
Found: Advertises starting options as low as $39 and notes most insurance is now accepted. Found handles insurance paperwork and markets having options to use insurance benefits to save on compound GLP-1s for some patients. Pricing and coverage vary by insurance and may require commitments for advertised branded GLP-1 pricing.
Check Found plans and insurance options
Embody: Promotes a flat cash price of $69/month for compounded semaglutide (reduced from $299) and $119/month for compounded tirzepatide, with no insurance required. Embody advertises no membership and cancel anytime flexibility. Final pricing may vary by dose and clinician recommendation, and the $69 price is noted as a limited-time offer that may change.
Get Embody pricing and shipping details
3. Medication types and regulatory notes
Found: Offers both compounded and branded GLP-1 options including semaglutide and tirzepatide and references branded GLP-1s such as Wegovy and Zepbound with specific offer terms. The provider explicitly states that certain medications are FDA-approved for conditions other than weight and that compounded GLP-1s are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality.
Embody: Offers compounded semaglutide and tirzepatide only. Embody notes its compounded medications are not FDA-approved finished products and that prescriptions follow a licensed provider review with pharmacy fulfillment. Embody does not offer branded Ozempic, Wegovy, or Zepbound.
4. Delivery, membership, and speed
Found: Emphasizes membership plans and handling insurance paperwork. Found advertising shows membership starting points and mentions options tied to insurance commitments for certain prices. Specific delivery timing was not supplied in the captured Found evidence.
Embody: Promises free shipping with delivery in 1–2 days after clinician approval and highlights no monthly membership and cancel anytime policies. Embody markets fast delivery as one of its features.
Comparison table: Found vs Embody
| Criteria | Found | Embody |
|---|---|---|
| Starting price | Get started for as low as $39 | $69/month for compounded semaglutide |
| Insurance | Most insurance now accepted; Found handles paperwork | No insurance; direct-pay cash pricing |
| Care model | Personalized, biology-first medically supervised program | Prescription-forward telehealth with clinician review |
| Medication types | Compounded and branded GLP-1s available | Compounded semaglutide and tirzepatide only |
| Shipping / delivery | Not specified in captured evidence | Free shipping, arrives in 1–2 days after approval |
| Membership | Membership plans with variable pricing and terms | No monthly membership; cancel anytime |
What the sources say about risks and limits
Both providers include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Found also notes that certain medications are FDA-approved for conditions other than weight and that Rx is subject to provider review and clinical eligibility. Embody notes final pricing may vary by dose and clinician recommendation.
Bottom line: Found vs Embody
Found focuses on a biology-first, medically supervised program that can work with many insurance plans and offers both compounded and branded GLP-1s. Embody focuses on aggressive cash pricing for compounded semaglutide and tirzepatide, plus free 1–2 day shipping and no requirement to use insurance. Use the comparison above to prioritize personalization and insurance support or to prioritize low cash price and fast delivery.
Explore Found personalized plans
Start Embody for fast compounded GLP-1
Choose Found if…
- You want a medically supervised, biology-based weight loss program that may work with most insurance and offers both compounded and branded GLP-1 options.
Choose Embody if…
- You want the lowest cash entry price for compounded semaglutide or tirzepatide, fast free 1–2 day shipping after approval, and no insurance required.